This company seems to have been delisted
Reason: Acquired by Globus Medical
Last recorded trade on: November 3, 2023
Source: https://www.sandiegouniontribune.com/business/story/2023-02-09/san-diego-spine-surgery-firm-nuvasive-acquired-by-rival-globus-medical-in-3-1-billion-all-stock-deal
Reason: Acquired by Globus Medical
Last recorded trade on: November 3, 2023
Source: https://www.sandiegouniontribune.com/business/story/2023-02-09/san-diego-spine-surgery-firm-nuvasive-acquired-by-rival-globus-medical-in-3-1-billion-all-stock-deal
NuVasive
NUVA
$69.64
Share price
0.00%
Change (1 day)
13.78%
Change (1 year)
Categories
Revenue for NuVasive (NUVA)
Revenue in 2023 (TTM): NZ$2.00 Billion
According to NuVasive's latest financial reports the company's current revenue (TTM 
) is NZ$2.14 Billion. In 2022 the company made a revenue of NZ$1.89 Billion an increase over the revenue in the year 2021 that were of NZ$1.66 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for NuVasive from 2004 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | NZ$2.00 B | 6.17% |
| 2022 | NZ$1.89 B | 13.53% |
| 2021 | NZ$1.66 B | 14.53% |
| 2020 | NZ$1.45 B | -16.05% |
| 2019 | NZ$1.73 B | 5.6% |
| 2018 | NZ$1.64 B | 13.3% |
| 2017 | NZ$1.44 B | 4.37% |
| 2016 | NZ$1.38 B | 17.19% |
| 2015 | NZ$1.18 B | 21.79% |
| 2014 | NZ$0.97 B | 16.7% |
| 2013 | NZ$0.83 B | 10.58% |
| 2012 | NZ$0.75 B | 8.87% |
| 2011 | NZ$0.69 B | 11.72% |
| 2010 | NZ$0.61 B | 21.57% |
| 2009 | NZ$0.50 B | 18.31% |
| 2008 | NZ$0.43 B | 113.96% |
| 2007 | NZ$0.20 B | 44.67% |
| 2006 | NZ$0.13 B | 54.02% |
| 2005 | NZ$90.4 M | 67.97% |
| 2004 | NZ$53.81 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | NZ$1.40 B | -34.80% | 🇺🇸 USA |
 | NZ$39.58 B | 1,742.65% | 🇺🇸 USA |
 | NZ$4.41 B | 105.46% | 🇺🇸 USA |
 | NZ$58.16 B | 2,607.41% | 🇮🇪 Ireland |